Fosun International Ltd. Says Its M&A/Operating Strategy Designed To Meet Next-Gen Business World

April 4, 2017 -- In an annual letter to shareholders, China conglomerate Fosun International, the parent of Fosun Pharma, said its heavy use of M&A is designed to promote two linked goals: C2M and a closed loop. C2M (customer-to-maker) describes the internet world that has, in many cases, done away with intermediaries, allowing customers to talk directly to companies -- and vice-versa with targeted advertising. The closed loop is a result of C2M, allowing a company to dominate the varied stages of a particular industry. It is especially evident in healthcare. For Fosun, the closed loop includes health insurance, health management, healthcare delivery, pharmaceutical drugs and medical devices. Fosun is active in each segment.